friedreich's ataxia: creative concepts for consumer campaigns
Client: REATA Pharmaceuticals' SKYCLARYS for Friedreich's Ataxia (FA)
Background and Challenge: Similar to ALS, FA is a rare, progressive neuromuscular disorder that reduces the body's ability to move. SKYCLARYS is the first FDA-approved treatment for FA; it acts to slow the progress of the disease, enabling patients (typically diagnosed in their teens or 20s), to get more out of life.
Solution: Worked with my art director partner Slade Seaholm to bring these creative concepts to life.
Background and Challenge: Similar to ALS, FA is a rare, progressive neuromuscular disorder that reduces the body's ability to move. SKYCLARYS is the first FDA-approved treatment for FA; it acts to slow the progress of the disease, enabling patients (typically diagnosed in their teens or 20s), to get more out of life.
Solution: Worked with my art director partner Slade Seaholm to bring these creative concepts to life.
"More you. Less FA"
"GO WITH PLAN A"
Michael Berliner is an experienced copywriter based in the Triangle area of North Carolina (Raleigh, Durham, Chapel Hill). Get in touch with Michael